Agency Continues to Take Steps to Reduce New Cases of Opioid Use Disorder SILVER SPRING, Md., April 3, 2023 /PRNewswire/ — Today, the U.S. Food and Drug Administration announced it is requiring manufacturers of opioid analgesics dispensed in outpatient settings to make prepaid mail-back…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.